small win: REDEFINE stopped being a problem at week 21
Quick one. Canada here.
CagriSema works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US.
Specifics: the route I used took 11 weeks and cost roughly what I expected. The admin was worse than the cost. The thing that would have saved me the most time was knowing which document to ask for at the start.
Happy to answer questions from anyone in the same jurisdiction.
best — the order this archive was captured in
The satiety on amylin analogs is described as physically different. GLP-1 reduces appetite noise, amylin does co-agonism.
amylin is not a GLP-1, posts conflating them get corrected
REDEFINE phase 17 readouts are interesting but 17 person CagriSema is different from 17 trial CagriSema.
the co-agonism question is real and interesting
amylin receptor distribution is different from GLP-1
amylin receptor distribution is different from GLP-1
Adding to this: REDEFINE is doing more work than the comment implies.
CagriSema ratios in trials are fixed, do not extrapolate self-mixing
the mechanism is different, the side effect profile reflects it
Not convinced. The evidence does not support that reading.
This is the "correlation is mechanism" thing again. You changed three variables at once.
CagriSema is a fixed combo in trials, not user-mixed
Strongly agree. REDEFINE is phase 14, not final.
Yeah, amylin is doing different work than GLP-1.
The research community is small on cagrilintide. Forum lore changes faster than data.
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
That is net peptide content, not purity. Different number, different meaning.
Small correction: the trial was 15 weeks, not 15. Does not change your point but people will quote it.
This is correct. The co-agonism is real.
REDEFINE phase 12 readouts are interesting but 12 person REDEFINE is different from 12 trial REDEFINE.
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
the mechanism is different, the side effect profile reflects it
- 1amylin receptor distribution is different from GLP-17 comments in this branch · started by u/noor_ivaturi
- 2The satiety on amylin analogs is described as physically different. GLP-1…6 comments in this branch · started by u/emil_agyeman